Biotechnology company
HR 4710, 340B Pause Act, and issues relating generally to the 340B Drug Discount Program; issues relating to drug pricing policies. HR 4710, 340B Pause Act and other issues relating generally to the 340B Drug Discount Program; issues relating to Medicare and Medicaid coverage and a reimbursement. Prescription Drug User Fee Act reauthorization.
HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LA and Chief Counsel, Rep. Bart Stupak; LA Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo)
LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LA and Chief Counsel, Rep. Bart Stupak; LA Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo